Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Drug Discovery Today
|
May 13, 2014
mitoNEET as a novel drug target for mitochondrial dysfunction
Werner J Geldenhuys, Thomas C Leeper, Richard T Carroll
Current Pharmaceutical Biotechnology
|
April 7, 2011
Natural products of dietary origin as lead compounds in virtual screening and drug design
Werner J Geldenhuys, Anupam Bishayee, Altaf S Darvesh, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2010
Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET
Werner J Geldenhuys, Max O Funk, Kendra F Barnes, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 27, 2010
Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis
Anupam Bishayee, Kendra F Barnes, Deepak Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET
Werner J Geldenhuys, Max O Funk, Prabha S Awale, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 10, 2012
A scaffold hopping approach to identify novel monoamine oxidase B inhibitors
Werner J Geldenhuys, Max O Funk, Cornelis J Van der Schyf, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 29, 2024
Iron-sulfur cluster redox chemistry and dimer dissociation in the outer mitochondrial membrane protein, mitoNEET
Kanita A Chaudhry, Krishani K Rajanayake, Richard T Carroll, et al.
Biochemistry
|
May 20, 2011
Complexes of the outer mitochondrial membrane protein mitoNEET with resveratrol-3-sulfate
Waqar Arif, Shu Xu, Dragan Isailovic, et al.
Progress in Neurobiology
|
May 4, 2011
The emergence of designed multiple ligands for neurodegenerative disorders
Werner J Geldenhuys, Moussa B H Youdim, Richard T Carroll, et al.
Journal of Drug Targeting
|
February 18, 2010
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders
Richard T Carroll, Deepak Bhatia, Werner Geldenhuys, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Drug Discovery Today
|
May 13, 2014
mitoNEET as a novel drug target for mitochondrial dysfunction
Werner J Geldenhuys, Thomas C Leeper, Richard T Carroll
Current Pharmaceutical Biotechnology
|
April 7, 2011
Natural products of dietary origin as lead compounds in virtual screening and drug design
Werner J Geldenhuys, Anupam Bishayee, Altaf S Darvesh, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2010
Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET
Werner J Geldenhuys, Max O Funk, Kendra F Barnes, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 27, 2010
Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis
Anupam Bishayee, Kendra F Barnes, Deepak Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET
Werner J Geldenhuys, Max O Funk, Prabha S Awale, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 10, 2012
A scaffold hopping approach to identify novel monoamine oxidase B inhibitors
Werner J Geldenhuys, Max O Funk, Cornelis J Van der Schyf, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 29, 2024
Iron-sulfur cluster redox chemistry and dimer dissociation in the outer mitochondrial membrane protein, mitoNEET
Kanita A Chaudhry, Krishani K Rajanayake, Richard T Carroll, et al.
Biochemistry
|
May 20, 2011
Complexes of the outer mitochondrial membrane protein mitoNEET with resveratrol-3-sulfate
Waqar Arif, Shu Xu, Dragan Isailovic, et al.
Progress in Neurobiology
|
May 4, 2011
The emergence of designed multiple ligands for neurodegenerative disorders
Werner J Geldenhuys, Moussa B H Youdim, Richard T Carroll, et al.
Journal of Drug Targeting
|
February 18, 2010
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders
Richard T Carroll, Deepak Bhatia, Werner Geldenhuys, et al.
Page
of 2